Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Pharmaco (NZ) Ltd,Budesonide controlled-release,"Ulcerative colitis, mild to moderately active",Budesonide controlled-release,Options for investment,Community and Hospital,Alimentary Tract and Metabolism
